Cabaletta Bio Inc. (CABA) PT Lowered to $25 at Morgan Stanley
Tweet
Share
E-mailGet Alerts CABA Hot Sheet
Price: $2.89 --0%
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 25
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 25
Join SI Premium – FREE
Morgan Stanley analyst Michael Ulz lowered the price target on Cabaletta Bio Inc. (NASDAQ: CABA) to $25.00 (from $28.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
- CLSA Upgrades Carabao Group (BK:CBG) to Hold (3)
- Asahi Group Holdings Ltd. (2502:JP) (ASBRY) PT Lowered to JPY2,452 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
